These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1643358)

  • 1. [Effectiveness of the use of zaditen and leakadin in recurrent erysipelas].
    Frolov VM; Peresadin NA; Pinskiĭ LL; Korobka IuN; Pustovoĭ IuG
    Ross Med Zh; 1992; (3):38-9. PubMed ID: 1643358
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effectiveness in treating patients with different clinical forms of erysipelas].
    Kriukova ZV; Kriukova SA; Panichkina LN
    Vrach Delo; 1986 Aug; (8):121-2. PubMed ID: 3776149
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of vilozen and ketotifen combination for increasing the effectiveness and prevention of complications of antibiotic therapy of streptococcal infections].
    Frolov VM; Peresadin NA; Pustovoĭ IuG
    Antibiot Khimioter; 1992 May; 37(5):44-6. PubMed ID: 1417331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical effectiveness and prospects for using zaditen (ketotifen) in the therapy of allergic dermatoses].
    Sergeev IuV; Potekaev NS
    Vestn Dermatol Venerol; 1987; (4):52-5. PubMed ID: 3604448
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of pyrogenal in the combined therapy of erysipelas].
    Zhivitsa LV; Zeĭgermakher GA; Knysh EN; Predeina VA
    Vrach Delo; 1986 Oct; (10):24-6. PubMed ID: 3798883
    [No Abstract]   [Full Text] [Related]  

  • 6. [Ketotifen treatment of bronchial asthma].
    Landyshev IuS; Goborov ND; Iugaĭ AL
    Sov Med; 1989; (12):68-70. PubMed ID: 2631254
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effectiveness of immunocorrective therapy of recurrent erysipelas].
    Frolov VM; Rychnev VE; Peresadin NA
    Klin Med (Mosk); 1985 Jul; 63(7):69-73. PubMed ID: 4046540
    [No Abstract]   [Full Text] [Related]  

  • 8. [T-activin in the treatment of patients with recurrent erysipelas and concomitant eczema].
    Frolov VM; Peresadin NA; Gaĭdash IS; Baskakov IN; Tishchenko NA
    Vestn Dermatol Venerol; 1989; (9):47-51. PubMed ID: 2609765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prostaglandins in erysipelas].
    Cherkasov VL; Bol'shakova TD; Meshcheriakova SV; Mikerin SM
    Sov Med; 1986; (8):26-8. PubMed ID: 3465043
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effectiveness of prodigiozan in the complex treatment of erysipelas].
    Frolov VM; Rychnev VE
    Klin Med (Mosk); 1984 Aug; 62(8):123-6. PubMed ID: 6387266
    [No Abstract]   [Full Text] [Related]  

  • 11. A steroid-sparing effect of ketotifen in steroid dependent asthmatics.
    Madalinska M; Droszcz W; Felczak-Chazan R
    Allergol Immunopathol (Madr); 1985; 13(1):9-11. PubMed ID: 4003227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Zaditen-Intal and combined prophylaxis in asthmatic children.
    Osváth P; Endre L
    Allergol Immunopathol (Madr); 1983; 11(1):24-7. PubMed ID: 6407290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Principles of treatment of patients with recurrent erysipelas].
    Cherkasov VL; Samotolkin KN
    Vrach Delo; 1983 Feb; (2):113-6. PubMed ID: 6845687
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pyrogenal in the combined therapy of erysipelatous inflammation].
    Frolov VM; Shlykova SI
    Sov Med; 1984; (1):95-8. PubMed ID: 6701664
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of Zaditen in patients with atopic bronchial asthma at Sandanski health resort].
    Petrov D; Stoeva N
    Vutr Boles; 1984; 23(2):98-101. PubMed ID: 6741117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Erysipelas: epidemiological, clinical and therapeutic data (111 cases)].
    Crickx B; Chevron F; Sigal-Nahum M; Bilet S; Faucher F; Picard C; Lazareth I; Belaich S
    Ann Dermatol Venereol; 1991; 118(1):11-6. PubMed ID: 2018300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intralymphatic antibiotic therapy in erysipelas of the lower limbs].
    Ermolov AS; Cherkasov VL; Udovskiĭ EE; Samotolkin KN; Ryskind RR; Grigorian AR; Mamedov BA
    Sov Med; 1989; (8):95-9. PubMed ID: 2814680
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunomodulating therapy of middle-aged and elderly patients with erysipelas].
    Frolov VM; Rychnev VE; Razenkova AT; Baskakov IN; Gurina AA
    Vrach Delo; 1987 Jul; (7):103-5. PubMed ID: 3630100
    [No Abstract]   [Full Text] [Related]  

  • 19. [The prevention of recurrent erysipelas].
    van Furth R
    Ned Tijdschr Geneeskd; 1992 Oct; 136(42):2049-51. PubMed ID: 1407204
    [No Abstract]   [Full Text] [Related]  

  • 20. [Long-term preventive use of sulfamerazine in chronic recurrent erysipelas].
    Härtel S; Gramatté T; Scholz A; Terhaag B
    Dermatol Monatsschr; 1988; 174(8):485-92. PubMed ID: 3139469
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.